Eaton Vance Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,000
| Closed | -$67K | – | 2926 |
|
|
2021
Q3 | $67K | Sell |
11,000
-40,900
| -79% | -$249K | ﹤0.01% | 1489 |
|
|
2021
Q2 | $427K | Buy |
51,900
+14,000
| +37% | +$115K | ﹤0.01% | 1379 |
|
|
2021
Q1 | $339K | Buy |
37,900
+7,400
| +24% | +$66.2K | ﹤0.01% | 1366 |
|
|
2020
Q4 | $352K | Buy |
30,500
+12,900
| +73% | +$149K | ﹤0.01% | 1299 |
|
|
2020
Q3 | $183K | Buy |
+17,600
| New | +$183K | ﹤0.01% | 1299 |
|
|
2018
Q1 | – | Sell |
-12,900
| Closed | -$323K | – | 1167 |
|
|
2017
Q4 | $323K | Buy |
12,900
+3,500
| +37% | +$87.6K | ﹤0.01% | 1036 |
|
|
2017
Q3 | $227K | Buy |
+9,400
| New | +$227K | ﹤0.01% | 1066 |
|